biosig_rgb.png
BioSig Technologies Announces EU Institutional Investor Roadshow
January 30, 2017 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 30, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies to Present at Monaco Growth Conference in Dubai, U.A.E.
January 25, 2017 09:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 25, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies Issues Shareholder Letter
January 20, 2017 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 20, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies’ PURE EP System Featured in The Journal of the American College of Cardiology: Clinical Electrophysiology
January 11, 2017 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary technology platform designed to improve the $4 billion...
biosig_rgb.png
BioSig Technologies To Present Today At The Emerging Medical Technologies Summit
November 11, 2016 07:15 ET | BioSig Technologies, Inc.
Minneapolis, MN, Nov. 11, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP)...
Parion Corporate Logo-01.png
Parion Sciences Announces Presentation of Clinical Data with Novel Pulmonary Delivery Device at the 2016 North American Cystic Fibrosis Conference
October 25, 2016 08:14 ET | Parion Sciences
DURHAM, N.C., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced that an abstract from its...
biosig_rgb.png
BioSig Technologies to Present at The MicroCap Conference in Philadelphia
October 19, 2016 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP™ System, a novel cardiac electrophysiology (EP) signal...
biosig_rgb.png
BioSig Technologies to Present at the Dawson James 2016 Small Cap Growth Stock Conference
October 12, 2016 08:06 ET | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 12, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP)...
BioSig Technologies to Present at the Fifth Annual OktoberINVESTfest, US – Bavaria, Germany Investors Conference In New York
September 27, 2016 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Sept. 27, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP)...
biosig_rgb.png
BioSig Technologies Sponsors The 11th International Symposium on Ventricular Arrhythmias
September 26, 2016 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Sept. 26, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP)...